Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Work In Process (2018 - 2021)

Historic Work In Process for Medifast (MED) over the last 4 years, with Q3 2021 value amounting to $3.4 million.

  • Medifast's Work In Process rose 2296.27% to $3.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $3.4 million, marking a year-over-year increase of 2296.27%. This contributed to the annual value of $4.1 million for FY2020, which is 92.48% down from last year.
  • Per Medifast's latest filing, its Work In Process stood at $3.4 million for Q3 2021, which was up 2296.27% from $3.0 million recorded in Q2 2021.
  • Medifast's 5-year Work In Process high stood at $4.1 million for Q4 2019, and its period low was $1.6 million during Q4 2018.
  • For the 4-year period, Medifast's Work In Process averaged around $2.9 million, with its median value being $2.9 million (2020).
  • In the last 5 years, Medifast's Work In Process surged by 16289.19% in 2019 and then tumbled by 2313.47% in 2020.
  • Over the past 4 years, Medifast's Work In Process (Quarter) stood at $1.6 million in 2018, then surged by 162.89% to $4.1 million in 2019, then fell by 0.92% to $4.1 million in 2020, then fell by 16.61% to $3.4 million in 2021.
  • Its Work In Process stands at $3.4 million for Q3 2021, versus $3.0 million for Q2 2021 and $2.5 million for Q1 2021.